Biodesix, Inc. (BDSX)
25.62
-0.40
(-1.56%)
USD |
NASDAQ |
Oct 12, 16:00
25.62
0.00 (0.00%)
After-Hours: 17:03
Biodesix Cash from Investing (Quarterly) : -0.254M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.254M |
| March 31, 2026 | -0.144M |
| December 31, 2025 | -0.104M |
| September 30, 2025 | -0.067M |
| June 30, 2025 | -0.095M |
| March 31, 2025 | -0.137M |
| December 31, 2024 | -0.884M |
| September 30, 2024 | -0.286M |
| June 30, 2024 | -1.997M |
| March 31, 2024 | -0.273M |
| December 31, 2023 | -3.001M |
| September 30, 2023 | -5.883M |
| June 30, 2023 | -6.472M |
| March 31, 2023 | -7.706M |
| Date | Value |
|---|---|
| December 31, 2022 | -1.987M |
| September 30, 2022 | -0.815M |
| June 30, 2022 | -0.38M |
| March 31, 2022 | -0.352M |
| December 31, 2021 | -0.641M |
| September 30, 2021 | -1.042M |
| June 30, 2021 | -0.348M |
| March 31, 2021 | -0.516M |
| December 31, 2020 | -0.543M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -0.392M |
| December 31, 2019 | -0.878M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| OPKO Health, Inc. | 15.54M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -8.319M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.601M |
| Cash from Financing (Quarterly) | 6.279M |
| Free Cash Flow | -20.47M |
| Free Cash Flow Per Share (Quarterly) | -0.1802 |
| Free Cash Flow to Equity (Quarterly) | -2.041M |
| Free Cash Flow to Firm (Quarterly) | 0.127M |
| Free Cash Flow Yield | -9.00% |